Meeting
2014 ASCO Annual Meeting
Inferior local control for T2bN0 glottic carcinoma with impaired mobility treated with radiation alone: A need for more chemotherapy?
Authors
Priyanka Bhateja
Cleveland Clinic Foundation, Cleveland, OH
Priyanka Bhateja , Matthew C Ward , John Greskovich , Chandana A. Reddy , Tobenna Igweonu Nwizu , David J. Adelstein , Shlomo A. Koyfman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 6084)
DOI
10.1200/jco.2014.32.15_suppl.6084
Abstract #
6084
Poster Bd #
119
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Atezolizumab plus tiragolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal: TIRANUS (GEMCAD-2103) trial.
First Author: Jaume Capdevila
Poster
2023 ASCO Annual Meeting
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.
First Author: Thiago Bueno Oliveira Sr.
Poster
2023 ASCO Annual Meeting
Induction chemotherapy with nanosomal docetaxel lipid suspension (NDLS), cisplatin, and fluorouracil in patients with locally advanced head and neck squamous cell carcinoma.
First Author: Ghanashyam Biswas